Dawes Karen A is a director of Barinthus Biotherapeutics Plc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Feb 24 | RGEN Repligen | Common Stock | Sell | Dispose S | No | No | 193.35 | 1,000 | 193.35 k | 87,367 |
27 Feb 24 | RGEN Repligen | Common Stock | Option exercise | Acquire M | No | No | 42.07 | 4,626 | 194.62 k | 88,367 |
27 Feb 24 | RGEN Repligen | Stock Option Common Stock | Option exercise | Acquire M | No | No | 42.07 | 4,626 | 194.62 k | 0 |
29 Aug 23 | RGEN Repligen | Common Stock | Sell | Dispose S | No | No | 171.38 | 850 | 145.67 k | 83,741 |
29 Aug 23 | RGEN Repligen | Common Stock | Option exercise | Acquire M | No | No | 18.12 | 7,392 | 133.94 k | 84,591 |
29 Aug 23 | RGEN Repligen | Stock Option Common Stock | Option exercise | Acquire M | No | No | 18.12 | 7,392 | 133.94 k | 0 |
18 May 23 | RGEN Repligen | Common Stock | Grant | Acquire A | No | No | 0 | 798 | 0.00 | 77,199 |
18 May 23 | RGEN Repligen | Stock Option Common Stock | Grant | Acquire A | No | No | 156.63 | 1,730 | 270.97 k | 1,730 |
11 May 23 | BRNS Barinthus Biotherapeutics | Share Option Ordinary Shares | Grant | Acquire A | No | No | 2.27 | 19,197 | 43.58 k | 19,197 |
15 Jun 22 | BRNS Barinthus Biotherapeutics | Share Option Ordinary Shares | Grant | Acquire A | No | No | 4.27 | 18,604 | 79.44 k | 18,604 |